BioSpace Collaborative

Academic/Biomedical Research
News & Jobs
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

PROFILES
Company Profiles

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Research Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search
 Company Profile

 

NanoBio Corporation 

P.O. Box 8110

Ann Arbor  Michigan  48107  U.S.A.
Phone: 734-302-4000 Fax: 734-302-6150


SEARCH JOBS

View Clinical Trials from BioPharm Insight




Segment
Start Up





 Company News
Merck & Co., Inc. (MRK) Licenses NanoBio Corporation Technology 3/27/2014 9:33:37 AM    More...
NanoBio Corporation Awarded Up to $10 Million in National Institutes of Health (NIH) Funding to Develop a Pandemic Influenza Vaccine 10/29/2013 11:26:48 AM    More...
NanoBio Corporation; Interscience Conference on Antimicrobial Agents and Chemotherapy 9/11/2013 9:45:47 AM    More...
NanoBio Corporation Closes $11 Million Series C Financing 11/28/2012 8:19:31 AM    More...
NanoBio Corporation Announces Data Presentation on Its Nanoemulsion Adjuvanted RSV Vaccine at IDWeek 2012 10/15/2012 10:08:05 AM    More...
NanoBio Corporation Promotes David Peralta to Chief Executive Officer 10/9/2012 8:28:16 AM    More...
NanoBio Corporation to Report Data on its Nanoemulsion Adjuvanted Intranasal RSV Vaccine at the 8th Annual International Respiratory Syncytial Virus Symposium 9/24/2012 10:03:04 AM    More...
NanoBio Corporation to Present Preclinical Data on its Nanoemulsion Adjuvanted Intranasal RSV Vaccine and Novel Inhaled Cystic Fibrosis Therapy at 52nd Annual ICAAC Meeting 9/10/2012 9:15:25 AM    More...
NanoBio Corporation to Collaborate in Research Effort for Respiratory Syncytial Virus Vaccine With Merck & Co., Inc. (MRK) 12/8/2011 9:34:40 AM    More...
NanoBio Corporation Secures Novel Antigen Source Through National Institutes of Health (NIH) for its Intranasal RSV Vaccine 8/3/2011 9:48:31 AM    More...
123456789